院外心脏骤停终止复苏方案的成本效果分析
该研究从医疗服务提供者视角构建Markov模型,比较无终止复苏、观察性终止复苏(反映现有实践)和完全终止复苏三种策略,模型周期为心脏骤停初始状态后30天,评估时间跨度10年,并进行概率敏感性分析。共分析3,695例符合终止复苏方案的院外心脏骤停病例,平均年龄73.0±15.5岁。每10,000例假设患者中,观察性终止复苏和完全终止复苏分别较无终止复苏多约19例和31例死亡;完全终止复苏成本最低为19,633,369美元(95%不确定性区间19,469,973至19,796,764),QALY为0。若对每例符合条件者实施终止复苏,相比无终止复苏每损失1个QALY可节省约400,440美元,相比观察性终止复苏每损失1个QALY可节省约821,151美元。作者认为该方案在可接受支付意愿阈值内具有成本效果,为可持续采用提供了一定依据。
要点
- 共分析3,695例符合终止复苏方案的院外心脏骤停病例,平均年龄73.0±15.5岁。
- 每10,000例假设患者中,观察性终止复苏和完全终止复苏分别较无终止复苏多约19例和31例死亡。
- 完全终止复苏成本最低为19,633,369美元(95%不确定性区间19,469,973至19,796,764),QALY为0。
- 若对每例符合条件者实施终止复苏,相比无终止复苏每损失1个QALY可节省约400,440美元,相比观察性终止复苏每损失1个QALY可节省约821,151美元。
- 作者认为终止复苏方案在可接受支付意愿阈值内具有成本效果,为可持续采用提供了一定依据。
适用人群与场景
- 新加坡符合终止复苏方案的院外心脏骤停病例,共3,695例,平均年龄73.0±15.5岁。
研究设计与关键结果
- 研究类型为成本效果分析,采用Markov模型,从医疗服务提供者视角比较无终止复苏、观察性终止复苏(反映现有实践)和完全终止复苏三种策略。
- 模型周期为心脏骤停初始状态后30天,评估时间跨度10年,并进行概率敏感性分析。
- 共分析3,695例符合终止复苏方案的院外心脏骤停病例,平均年龄73.0±15.5岁。
- 每10,000例假设患者中,观察性终止复苏和完全终止复苏分别较无终止复苏多约19例和31例死亡。
- 完全终止复苏成本最低为19,633,369美元(95%不确定性区间19,469,973至19,796,764),QALY为0。
- 若对每例符合条件者实施终止复苏,相比无终止复苏每损失1个QALY可节省约400,440美元,相比观察性终止复苏每损失1个QALY可节省约821,151美元。
证据类型、等级与局限
- 证据类型:成本效果分析(Markov模型研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对院外心脏骤停实施终止复苏方案在可接受支付意愿阈值内具有成本效果,为可持续采用提供了一定依据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Historically in Singapore, all out-of-hospital cardiac arrests (OHCA) were transported to hospital for pronouncement of death. A 'Termination of Resuscitation' (TOR) protocol, implemented from 2019 onwards, enables emergency responders to pronounce death at-scene in Singapore. This study aims to evaluate the cost-effectiveness of the TOR protocol for OHCA management.
METHODS: Adopting a healthcare provider's perspective, a Markov model was developed to evaluate three competing options: No TOR, Observed TOR reflecting existing practice, and Full TOR if TOR is exercised fully. The model had a cycle duration of 30 days after the initial state of having a cardiac arrest, and was evaluated over a 10-year time horizon. Probabilistic sensitivity analysis was performed to account for uncertainties. The costs per quality adjusted life years (QALY) was calculated.
RESULTS: A total of 3,695 OHCA cases eligible for the TOR protocol were analysed; mean age of 73.0 ± 15.5 years. For every 10,000 hypothetical patients, Observed TOR and Full TOR had more deaths by approximately 19 and 31 patients, respectively, compared to No TOR. Full TOR had the least costs and QALYs at $19,633,369 (95% Uncertainty Interval (UI) 19,469,973 to 19,796,764) and 0 QALYs. If TOR is exercised for every eligible case, it could expect to save approximately $400,440 per QALY loss compared to No TOR, and $821,151 per QALY loss compared to Observed TOR.
CONCLUSION: The application of the TOR protocol for the management of OHCA was found to be cost-effective within acceptable willingness-to-pay thresholds, providing some justification for sustainable adoption.
参考来源
- Nazeha N, Mao DR, Hong D, et al. Cost-effectiveness analysis of a 'Termination of Resuscitation' protocol for the management of out-of-hospital cardiac arrest. Resuscitation. 2024. PMID: 39029582. doi:10.1016/j.resuscitation.2024.110323
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。